We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > EpimAb

News List

Sherpa Healthcare Partners Announces the Successful Closing of Oversubscribed Fund II prnasia
July 21, 2021
Sherpa Healthcare Partners is pleased to announce the successful closing of the oversubscribed Sherpa Healthcare Fund II. The fund focuses on early- to growth-stage investments in China healthcare sector to cover companies in biotech/biopharma ...
EpimAb Biotherapeutics and QIMR Berghofer Medical Research Institute Announce Research Collaboration and License Agreement on Novel Bispecific Target Combinations en-cphi
April 23, 2020
EpimAb receives exclusive access to newly discovered target combinations in order to expand its proprietary pipeline
EpimAb announces IND filing for EMB01 biospectrumasia
September 18, 2018
IND filing marks further progress towards the first clinical trial with the Company’s Novel Bispecific Antibody Format.